218 related articles for article (PubMed ID: 15096160)
1. Corticosteroid iatrogenesis in a patient with palmoplantar psoriasis.
Gómez Vázquez M; Fernández-Redondo V; Toribio J
J Eur Acad Dermatol Venereol; 2004 May; 18(3):370-1. PubMed ID: 15096160
[No Abstract] [Full Text] [Related]
2. Leflunomide in the treatment of palmoplantar pustulosis.
Melwani PM; Peñate Y; Guillermo N; Soler E; Hernández-Machín B; Borrego L
Arch Dermatol; 2009 Nov; 145(11):1224-6. PubMed ID: 19917950
[No Abstract] [Full Text] [Related]
3. Corticosteroid therapy for pericarditis: a double-edged sword.
Imazio M; Brucato A; Trinchero R; Shabetai R; Spodick D; Adler Y
Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):118-9. PubMed ID: 18212773
[No Abstract] [Full Text] [Related]
4. [Current status of external corticosteroid therapy].
Gloor M
Fortschr Med; 1985 Feb; 103(5):82-6. PubMed ID: 3156081
[No Abstract] [Full Text] [Related]
5. Dermacase. Psoriasis.
Turchin I; Adams SP
Can Fam Physician; 2006 Sep; 52(9):1073, 1080. PubMed ID: 17279215
[No Abstract] [Full Text] [Related]
6. Topical corticosteroid-induced rosacea-like dermatitis: a clinical study of 110 cases.
Rathi SK; Kumrah L
Indian J Dermatol Venereol Leprol; 2011; 77(1):42-6. PubMed ID: 21220878
[TBL] [Abstract][Full Text] [Related]
7. Déjà vu all over again: skin cap still contains a high-potency glucocorticosteroid.
Swanson DL; Pittelkow MR; Benson LM; Hawkridge AM; Muddiman DC
Arch Dermatol; 2005 Jun; 141(6):801-3. PubMed ID: 15967944
[No Abstract] [Full Text] [Related]
8. Treatment of psoriasis with 6-thioguanine and hepatic venoocclusive disease.
Romagosa R; Kerdel F; Shah N
J Am Acad Dermatol; 2002 Dec; 47(6):970-2; author reply 972. PubMed ID: 12451396
[No Abstract] [Full Text] [Related]
9. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
[TBL] [Abstract][Full Text] [Related]
10. Current concepts and review of pimecrolimus in the treatment of psoriasis.
Wolff K
Dermatol Clin; 2004 Oct; 22(4):461-5, ix-x. PubMed ID: 15450341
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the effect of desoximetason-- a new local corticosteroid preparation].
Konzelmann H; Much T; Schwarz K
Schweiz Rundsch Med Prax; 1974 Jul; 63(28):878-81. PubMed ID: 4277933
[No Abstract] [Full Text] [Related]
12. Generalized pustular psoriasis (von Zumbusch) following iatrogenic hypocortisolism.
Augey F; Dissard C; Normand I; Daumont M
Eur J Dermatol; 2004; 14(6):415-7. PubMed ID: 15564207
[TBL] [Abstract][Full Text] [Related]
13. The right dose in the right place: an overview of current prescription, instruction and application modalities for topical psoriasis treatments.
Savary J; Ortonne JP; Aractingi S
J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():14-7. PubMed ID: 16274407
[TBL] [Abstract][Full Text] [Related]
14. Topical corticosteroids in psoriasis: strategies for improving safety.
Horn EJ; Domm S; Katz HI; Lebwohl M; Mrowietz U; Kragballe K;
J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):119-24. PubMed ID: 20175860
[TBL] [Abstract][Full Text] [Related]
15. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis.
Lin YK; Chang CJ; Chang YC; Wong WR; Chang SC; Pang JH
Arch Dermatol; 2008 Nov; 144(11):1457-64. PubMed ID: 19015420
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
Balkrishnan R; Camacho FT; Pearce DJ; Kulkarni AS; Spencer L; Fleischer AB; Feldman SR
J Drugs Dermatol; 2005; 4(6):699-706. PubMed ID: 16302555
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroids.
Isaksson M
Dermatol Ther; 2004; 17(4):314-20. PubMed ID: 15327476
[TBL] [Abstract][Full Text] [Related]
18. Retinoid therapy for psoriasis.
Yamauchi PS; Rizk D; Lowe NJ
Dermatol Clin; 2004 Oct; 22(4):467-76, x. PubMed ID: 15450342
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
[TBL] [Abstract][Full Text] [Related]
20. Dermoscopic assessment of long-term topical therapies with potent steroids in chronic psoriasis.
Vázquez-López F; Marghoob AA
J Am Acad Dermatol; 2004 Nov; 51(5):811-3. PubMed ID: 15523365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
